Isoliquiritigenin and licochalcone ASMEDDS further validate this approach, demonstrating XOD suppression, lymphatic transport enhancement, and mitigation of hyperuricemia-induced organ damage (Zhang Y
Jadidi, A., Rezaei Ashtiani, A., Khanmohamadi Hezaveh, A., & Aghaepour, S
Improved Blood Pressure and Cholesterol Levels In addition to their effects on blood glucose and weight, GLP-1 receptor agonists also contribute to improvements in blood pressure and lipid profiles, which can further reduce the risk of cardiovascular disease. Standard GLP-1 Dosing: What's Established Typical Doses The prescribed doses of GLP-1 receptor agonists are based on extensive clinical research and established therapeutic guidelines
Semaglutide, however, is already approved and has a long track record of success
doi: 10.1136/bmj.b2700